Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stanford University
Research
Harmless skin bacteria engineered to be living topical vaccine
When mice were colonized by these bacteria, they developed immunity to tetanus that prevented them from dying when later exposed to the toxin.
Darren Incorvaia
Dec 11, 2024 11:00am
Stanford economist is Trump's NIH pick—Chutes & Ladders
Dec 6, 2024 8:30am
Trump taps Stanford economic researcher as NIH head
Nov 27, 2024 10:33am
Trace uses $101M series A to go after same ALS target as Lilly
Nov 12, 2024 7:00am
Roche sues Stanford, Foresight Diagnostics over trade secrets
Jul 3, 2024 10:44am
Cell lines could lead to new drugs for deadly heart condition
Jun 4, 2024 2:12pm
